Toll-like receptors

Critical Care Medicine

Volumn 30, Issue 1 SUPPL. B, 2002, Pages

  Lien, Egil ^a   Ingalls, Robin R ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Bacterial proteins; Cell surface signal transduction; Immunity; Inflammation; Innate receptors; Lipopolysaccharide; Macrophage activation; Sepsis; Shock; Toll

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; LIPOPROTEIN; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

BINDING AFFINITY; CONFERENCE PAPER; DROSOPHILA MELANOGASTER; GENETIC POLYMORPHISM; IMMUNE SYSTEM; PHYLOGENY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEPSIS; SIGNAL TRANSDUCTION;

EID: 0036159869     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200201001-00001     Document Type: Conference Paper

References (209)

1. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
2. Cachectin: More than a tumor necrosis factor
3. Gram-negative endotoxin: E biologically active lipid
4. Biochemistry of endotoxins
5. Endotoxins and disease mechanisms
6. Prevention of Gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid
7. Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli
8. Endotoxaemia: An early predictor of septicaemia in febrile patients
9. Brief report: Shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin
10. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease
11. Changing ecology of bacterial infections as related to antibacterial therapy
12. Gram-negative bacteremia. III: Reassessment of etiology, epidemiology and ecology in 612 patients
13. Bacillus coli sepsis: A clinical study of twenty-eight cases of bloodstream infection by the colon bacillus
14. Bloodstream infections in urology: Report of 82 cases
15. Factors affecting mortality of Gram-negative rod bacteremia
16. Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases
17. Analysis of 1,186 episodes of Gram-negative bacteremia in non-university hospitals: The effects of antimicrobial therapy
18. Infections due to Gram-negative organisms: An analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966
19. Gram-negative bacteremia. IV: Re-evaluation of clinical features and treatment in 612 patients
20. Incidence and outcome of the respiratory distress syndrome in Gram-negative sepsis
21. Increasing threat of Gram-negative bacteria
22. Increasing threat of Gram-positive bacterial infections in the intensive care unit setting
23. The immune system evolved to discriminate infectious nonself from noninfectious self
24. Innate immunity
25. The instructive role of innate immunity in the acquired immune response
26. Establishment of dorsal-ventral polarity in the Drosophila embryo: Genetic studies on the role of the Toll gene product
27. Establishment of dorsal-ventral polarity in the Drosophila embryo: The induction of polarity by the Toll gene product
28. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults
29. Toll-related receptors and the control of antimicrobial peptide expression in Drosophila
30. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense
31. Drosophila Toll and IL-1 receptor
32. Signaling pathways that establish the dorsal-ventral pattern of the Drosophila embryo
33. The polarity of the dorsoventral axis in the Drosophila embryo is defined by an extracellular signal
34. Proteolytic processing of the Drosophila Spatzle protein by easter generates a dimeric NGF-like molecule with ventralising activity
35. An activity-dependent network of interactions links the Rel protein dorsal with its cytoplasmic regulators
36. Signal transduction by a protease cascade
37. Drosophila MyD88 is an adapter in the Toll signaling pathway
38. Cactus, a gene involved in dorsoventral pattern formation of Drosophila, is related to the I kappa B gene family of vertebrates
39. Characterization of the Drosophila cactus locus and analysis of interactions between cactus and dorsal proteins
40. The NE-kappa B and I kappa B proteins: New discoveries and insights
41. A conserved signaling pathway: The Drosophila Toll-dorsal pathway
42. The product of the tobacco mosaic virus resistance gene N: Similarity to Toll and the interleukin-1 receptor
43. Molecular genetics of plant disease resistance
44. Signaling in plant-microbe interactions
45. A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans
46. Molecular cloning and functional characterization of chicken Toll-like receptors: A single chicken Toll covers multiple molecular patterns
47. Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14
48. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
49. A family of human receptors structurally related to Drosophila Toll
50. Cloning and characterization of two Toll/ interleukin-1 receptor-like genes TIL3 and TIL4: Evidence for a multi-gene receptor family in humans
51. TLR6: A novel member of an expanding Toll-like receptor family
52. Three novel mammalian Toll-like receptors: Gene structure, expression, and evolution
53. Cloning and characterization of a sub-family of human Toll-like receptors: hTLR7, hTLR8 and hTLR9
54. A Toll-like receptor recognizes bacterial DNA
55. Identification of hTLR10: A novel human Toll-like receptor preferentially expressed in immune cells
56. The Toll/interleukin-1 receptor domain: A molecular switch for inflammation and host defence
57. Toll-like receptor family and signalling pathway
58. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
59. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells
60. Bacterial lipopolysaccharide activates NF-kappaB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells: Differential expression of TLR-4 and TLR-2 in endothelial cells
61. Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for escherichia and salmonella lipopolysaccharides
62. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens
63. Cutting edge: Role of Toll-like receptor 9 in cpg dna-induced activation of human cells
64. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4
65. Gene expressions of lipopolysaccharide receptors, Toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes
66. Expression of Toll-like receptor 2 on gammadelta T cells bearing invariant Vgamma6/ Vdeltal induced by Escherichia coli infection in mice
67. Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2
68. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses
69. Regulation of Toll-like receptors in human monocytes and dendritic cells
70. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide
71. Differential expression of Toll-like receptor 2 in human cells
72. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10
73. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes
74. Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages
75. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
76. Human Toll-like receptor 2 confers responsiveness to bacterial lipopoysaccharide
77. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
78. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product
79. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
80. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
81. Cutting edge: Cells that carry A null allele for Toll-like receptor 2 are capable of responding to endotoxin
82. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components
83. Cutting edge: Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2
84. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes
85. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
86. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation
87. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: Transfer from CD14 to TLR4 and MD-2
88. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages
89. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism
90. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4
91. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: A point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling
92. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4
93. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components
94. Cellular events mediated by lipopolysaccharide-stimulated Toll-like receptor 4
95. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells
96. MD-2 binds to bacterial lipopolysaccharide
97. Mouse Toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol
98. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol
99. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and Taxol-inducible gene expression
100. Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex
101. Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells
102. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
103. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
104. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2
105. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
106. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors
107. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
108. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors
109. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators
110. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3
111. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
112. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors
113. Cutting edge: Functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin
114. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling
115. Discrimination of bacterial lipoproteins by Toll-like receptor 6
116. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
117. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis
118. Maturation of human dendritic cells by cell wall skeleton of mycobacterium bovis bacillus calmette-Guerin: Involvement of Toll-like receptors
119. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2
120. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2
121. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection
122. Different Toll-like receptor agonists induce distinct macrophage responses
123. Cytokine-inducing macromolecular glycolipids from Enterococcus hirae: Improved method for separation and analysis of its effects on cellular activation
124. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids
125. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-kappaB translocation
126. Monocytic cell activation by nonendotoxic glycoprotein from Prevotella intermedia ATCC 25611 is mediated by Toll-like receptor 2
127. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite
128. Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through Toll-Like receptor 2
129. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2
130. An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells
131. A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/Toll-like receptor 4 signaling pathway
132. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses
133. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule
134. Involvement of CD14 and Toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae
135. The extra domain A of fibronectin activates Toll-like receptor 4
136. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4
137. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4
138. Cutting edge: Bacterial flagellin activates basolaterally expressed tlr5 to induce epithelial proinflammatory gene expression
139. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition
140. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein
141. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage
142. CD14: Cell surface receptor and differentiation marker
143. Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity
144. Lipopolysaccharide-induced stimulation of CD11b/CD18 expression on neutrophils: Evidence of specific receptor-based response and inhibition by lipid A-based antagonists
145. CD14 is a pattern recognition receptor
146. Mycobacterial lipoarabinomannan recognition requires a receptor which shares components of the endotoxin signaling system
147. Mechanisms of stimulation of interleukin-1beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components
148. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: Correlation to disease progression and clinical events
149. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity
150. Binding of bacterial peptidoglycan to CD14
151. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures
152. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes
153. Chemical characteristics of Staphylococcus aureus molecules that have CD14-dependent cell-stimulating activity
154. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses
155. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release
156. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers
157. The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14
158. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide
159. Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins
160. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi
161. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway
162. Analysis of lipopolysaccharide binding by CD14
163. CD14-deficient mice are exquisitely insensitive to the effects of LPS
164. Divergent response to LPS and bacteria in CD14-deficient murine macrophages
165. Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B
166. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide
167. CR3 (CD11b/CD18) expresses one binding Site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide
168. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide
169. Outside-in signaling by lipopolysaccharide through a tailless integrin
170. CD11b/CD18 acts in concert with CD14 and toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression
171. Soluble CD14 participates in the response of cells to lipopolysaccharide
172. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14
173. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64
174. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein
175. Endotoxin-neutralizing capacity of soluble CD14
176. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-alpha production by cells in whole blood
177. Cutting edge: Naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling
178. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways
179. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
180. IRAK: A kinase associated with the interleukin-1 receptor
181. TRAF6 is a signal transducer for interleukin-1
182. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway
183. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
184. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway
185. Unresponsiveness of MyD88-deficient mice to endotoxin
186. Endotoxin-induced maturation of MyD88-deficient dendritic cells
187. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta
188. TI-RAP: An adapter molecule in the Toll signaling pathway
189. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
190. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway
191. The apoptotic signaling pathway activated by Toll-like receptor-2
192. Induction of direct antimicrobial activity through mammalian Toll-like receptors
193. Endotoxin tolerance
194. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4
195. Reduced ex vivo interleukin-8 production by neutrophils in septic and nonseptic systemic inflammatory response syndrome
196. Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: Identification of interleukin-10 as a major functional deactivator of human monocytes
197. Cutting edge: Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression
198. Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways
199. Differential induction of endotoxin tolerance by lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli
200. Tolerance to lipopolysaccharide in human blood monocytes
201. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression
202. A inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo
203. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition
204. Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells
205. Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (Tlr4)
206. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
207. The role of endotoxin in grain dust-induced lung disease
208. A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease
209. A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection